Listen to Dr. Matthew Powell and Dr. Wendel Naumann discuss the 2024 SGO Annual Meeting on Women’s Cancer late-breaking abstract Overall survival in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY Recorded on April 23, 2024Duration approximately 15 minutesAttended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.
If you have questions or need assistance, contact education@igcs.org.
Matthew A. Powell, MDProfessor, Div Gyn OncologyChair Uterine Corpus CommitteeNational Cancer Institute sponsored NRG OncologyWashington University School of MedicineUSA
R. Wendel Naumann, M.D.Director of Gynecologic Oncology ResearchAssociate Medical Director of Clinical TrialsLevine Cancer Institute – Hall Gynecologic Oncology CenterUSA